UK signs deal with BioNTech for cutting-edge cancer trials

UK signs deal with BioNTech for cutting-edge cancer trials

Source: 
Financial Times
snippet: 

The UK government is partnering with German Covid-19 vaccine maker BioNTech to enrol up to 10,000 patients in clinical trials for cutting-edge cancer treatments.